1. Home
  2. TTE vs VRTX Comparison

TTE vs VRTX Comparison

Compare TTE & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTE
  • VRTX
  • Stock Information
  • Founded
  • TTE 1924
  • VRTX 1989
  • Country
  • TTE France
  • VRTX United States
  • Employees
  • TTE N/A
  • VRTX N/A
  • Industry
  • TTE Oil & Gas Production
  • VRTX EDP Services
  • Sector
  • TTE Energy
  • VRTX Technology
  • Exchange
  • TTE Nasdaq
  • VRTX Nasdaq
  • Market Cap
  • TTE 148.2B
  • VRTX 128.5B
  • IPO Year
  • TTE 1991
  • VRTX 1991
  • Fundamental
  • Price
  • TTE $59.66
  • VRTX $450.97
  • Analyst Decision
  • TTE Hold
  • VRTX Buy
  • Analyst Count
  • TTE 4
  • VRTX 29
  • Target Price
  • TTE $78.75
  • VRTX $513.58
  • AVG Volume (30 Days)
  • TTE 2.1M
  • VRTX 1.4M
  • Earning Date
  • TTE 10-31-2024
  • VRTX 11-04-2024
  • Dividend Yield
  • TTE 5.87%
  • VRTX N/A
  • EPS Growth
  • TTE N/A
  • VRTX N/A
  • EPS
  • TTE 7.09
  • VRTX N/A
  • Revenue
  • TTE $203,260,000,000.00
  • VRTX $10,625,800,000.00
  • Revenue This Year
  • TTE N/A
  • VRTX $12.20
  • Revenue Next Year
  • TTE N/A
  • VRTX $8.31
  • P/E Ratio
  • TTE $8.11
  • VRTX N/A
  • Revenue Growth
  • TTE N/A
  • VRTX 10.06
  • 52 Week Low
  • TTE $58.46
  • VRTX $346.29
  • 52 Week High
  • TTE $74.97
  • VRTX $519.88
  • Technical
  • Relative Strength Index (RSI)
  • TTE 32.62
  • VRTX 38.12
  • Support Level
  • TTE $58.46
  • VRTX $445.00
  • Resistance Level
  • TTE $61.76
  • VRTX $519.88
  • Average True Range (ATR)
  • TTE 0.85
  • VRTX 15.37
  • MACD
  • TTE 0.00
  • VRTX -5.29
  • Stochastic Oscillator
  • TTE 23.17
  • VRTX 7.97

About TTE TotalEnergies SE

TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 1.6 million barrels of liquids and 5.0 billion cubic feet of natural gas per day. At end-2023, reserves stood at 10.6 billion barrels of oil equivalent, 56% of which are liquids. During 2023, it had LNG sales of 44.3 metric tons. The company owns interests in refineries with capacity of nearly 2.0 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. At year-end, its gross installed renewable power generation capacity was 22.4 gigawatts.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: